Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1996
12/17/1996US5585374 Anxiolytic agents, antidepressants, cognition activators
12/17/1996US5585361 Intravenous administration of hyaluronic acid or its salts
12/17/1996US5585358 Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
12/17/1996US5585355 Drug delivery with a bradykinin derivatives
12/17/1996CA2111461C 3-aminopiperidine derivatives and related nitrogen containing heterocycles
12/14/1996CA2178849A1 N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics
12/12/1996WO1996039519A1 Kunitz type plasma kallikrein inhibitors
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039449A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039391A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996WO1996039390A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996WO1996039387A1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
12/12/1996WO1996039385A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
12/12/1996WO1996039168A1 Method for increasing hdl cholesterol level
12/12/1996WO1996039145A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
12/12/1996WO1996034010A3 Inhibitors of farnesyl-protein transferase
12/12/1996WO1996033730A3 Chemokine binding protein and methods of use therefor
12/12/1996WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
12/12/1996WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223585A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996CA2223393A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996CA2223388A1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223177A1 Method for increasing hdl cholesterol level
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2220130A1 Kunitz type plasma kallikrein inhibitors
12/12/1996CA2218531A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/11/1996EP0747393A1 Thiazolo benzazepine containing dual action inhibitors
12/11/1996EP0747392A1 1,2-Diazepine containing dual action inhibitors
12/11/1996EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747376A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747374A1 Sulfonamido substituted benzopyran potassium channel activators
12/11/1996EP0747357A2 Dihydropyridine NPY antagonists: piperidine derivatives
12/11/1996EP0747356A1 Dihydropyridine NPY antagonists: piperazine derivatives
12/11/1996EP0747354A1 3-Substituted oxindole derivatives as potassium channel modulators
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0747050A1 Pharmaceutical compositions containing irbesartan
12/11/1996EP0746566A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746551A1 Optically pure 4-aryl-2-hydroxytetronic acids
12/11/1996EP0746545A1 Nipecotic acid derivatives as antithrombic compounds
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
12/11/1996EP0746321A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/11/1996EP0746316A1 Therapeutic guanidines
12/11/1996EP0746315A1 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996EP0746202A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
12/11/1996EP0635010B1 Novel cardioprotective agents
12/11/1996EP0496832B1 Inhibition of padgem-mediated cell binding
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/11/1996CN1137520A Substituded indole derivatives
12/11/1996CN1137519A Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them
12/11/1996CN1137380A Use of phenylcyclohexylcarboxamides
12/10/1996US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides
12/10/1996US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives
12/10/1996US5583141 Heterocyclic compounds and their use as angiotensin antagonists
12/10/1996US5583127 17-iminomethylalkenyl-5 β, 14 β-androstane and 17-iminoalkyl-5 β, 14 β-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containing same
12/10/1996US5583126 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1996US5583117 Acylated uridine and cytidine for elevating tissue uridine and cytidine
12/10/1996US5582839 Administering intravenously to treat chronic cardiac condition such as myocardial infarction
12/10/1996CA2178548A1 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydro-quinazolinedione derivatives as .alpha.1 adrenergic receptor antagonists
12/10/1996CA2104456C Pyridine- and imidazole-derived agents for cardiovascular diseases
12/10/1996CA2007983C Coenzyme q10 with hmg-coa reductase inhibitors
12/10/1996CA1338786C (aryl or heteroaromatic methyl)-2,2'-bi-1h-imidazoles
12/10/1996CA1338776C Use of transglutaminases as immunosuppressants
12/08/1996CA2178413A1 Dihydropyridine npy antagonists: piperazine derivatives
12/08/1996CA2178355A1 Diazepine containing dual action inhibitors
12/08/1996CA2178353A1 Sulfonamido substituted benzopyran derivatives
12/08/1996CA2178352A1 Thiazolo benzazepine containing dual action inhibitors
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178183A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2177110A1 Dihydropyridine npy antagonists: piperidine derivatives
12/05/1996WO1996038579A1 High-affinity oligonucleotide ligands to growth factors
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038154A1 Means for treating radiation injuries
12/05/1996WO1996038148A1 Method for preventing intervention-associated stenosis following non-bypass, invasive interventions
12/05/1996WO1996038145A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996WO1996038144A1 Isothiazolones
12/05/1996WO1996038142A1 1h-4(5)-substituted imidazole derivatives
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222539A1 Agent for the treatment of radiation injuries
12/05/1996CA2222292A1 Methods for inhibiting vascular smooth muscle cell migration
1 ... 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 ... 1595